5-amino-1mq clinical trial human Reduced calorie diet combined with NNMT inhibition establishes a distinct microbiome in DIO mice 5-Amino-1MQ 50mg | Bluewell Peptides

Activates the SIRT3 pathway, alleviates hepatic inflammation and oxidative stress, protects hepatocytes, and slows MASH progression

The examples below use 1.0 mL for a 10 mg vial, 2.0 mL for a 20 mg vial, and 3.0 mL for a 50 mg vial

Some independent researchers recommend taking the full daily dose on an empty stomach, first thing in the morning

It is only available as a research compound

Injections should be no closer than an inch from each other

Theoretical concerns are not proof of harm, but they identify areas off-target SAM effects, signalling-pathway impacts, and uncharacterised interactions that require study before any conclusion about human safety could be drawn